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bei Isolaten, die zur Phylogruppe B2 (mittlere Gesamtzahlrate 6, Hauptrate 5.5, Streubreite 3-7) gehören,
am niedrigsten für Isolate der Phylogruppe C (0/ 0.5/ 0-3). Der häufigste ST in dieser Studie, ST410,
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nary tract infection (UTI) in humans, suggesting zoonotic potential. Among seven virulence-associated
genes, fyuA was the most prevalent. The overall aggregate virulence factor (VF) score was highest for
isolates belonging to phylogenetic group B2 (median aggregate VF score 6, mean score 5,5, range 3- 7),
and lowest for isolates belonging to phylogenetic group C (0/ 0.5/0-3). The most frequent ST in this
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Abstract 
 
Among 64 uropathogenic Escherichia coli (UPEC) isolated from 13 cats and 51 dogs, 35 
were extended-spectrum beta-lactamase (ESBL) producers, and 29 were non-ESBL 
producers. Forty-six (71.9%) of the isolates were multidrug resistant (MDR). Among the 
ESBL producers, blaCTX-M-15 (n=17/48.6% of the blaESBLs), blaCTX-M-1 (n=10/28.6%), blaCTX-M-
55 (n=4/11.4%), blaCTX-M-14 (n=3/8.6%), and blaCTX-M-27 (n=1/2.9%) were identified. The 
plasmid-mediated fluoroquinolone resistance genes aac(6')-Ib-cr, qnrB and the azithromycin 
resistance gene mph(A) were detected in 17 (26.6% of all isolates), one (1.6%) and in 13 
(20.3%) respectively. The most frequent phylogenetic groups were C (n=19) and B2 (n=15). 
Twenty-six different sequence types (STs) were identified, with two being novel. The most 
frequent STs were ST410 (n=16/25%), ST131, and ST73 (both n=5/7.8%), and ST361 
(n=4/6.3%). Ten (15.6%) of the STs have been associated with urinary tract infection (UTI) in 
humans, suggesting zoonotic potential. Among seven virulence-associated genes, fyuA was 
the most prevalent. The overall aggregate virulence factor (VF) score was highest for isolates 
belonging to phylogenetic group B2 (median aggregate VF score 6, mean score 5,5, range 3-
7), and lowest for isolates belonging to phylogenetic group C (0/ 0.5/0-3). The most frequent 
ST in this study, ST410, harboured the lowest number of VF (0/0,3/0-2).  
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Zusammenfassung 
 
Unter 64 uropathogenen Escherichia coli (UPEC), welche von 13 Katzen und 51 Hunden 
isoliert wurden, fanden sich 35 extended-spectrum -Lactamase (ESBL) produzierende 
UPEC, die restlichen 29 waren nicht-ESBL Bildner. 46 (71.9%) Isolate waren multiresistent 
(MDR). Innerhalb der ESBL Bildner wurden folgende blaESBL Gene identifiziert: blaCTX-M-15 
(n=17/48.6%), blaCTX-M-1 (n=10/28.6%), blaCTX-M-55 (n=4/11.4%), blaCTX-M-14 (n=3/8.6%) und 
blaCTX-M-27 (n=1/2.9%). Die Plasmid-mediierten Gene der Fluorchinolonresistenz aac(6')-Ib-
cr und qnrB sowie das Azithromycinresistenzgen mph(A) wurden in 17 (26.6%) Isolaten, 
beziehungsweise in einem (1.6%) und in 13 (20.3%) gefunden. Die am häufigsten 
vorkommenden Phylogruppen waren Gruppe C (n=19) und B2 (n=15). Es wurden 26 
verschiedene Sequenz-Typen (ST) identifiziert, wobei zwei davon neu waren. Die häufigsten 
ST waren ST410 (n=16/25%), ST131 und ST73 (beide n=5/7.8%) und ST361 (n=4/6.3%). 
Zehn (15.6%) der ST stehen in Verbindung zu Harnwegsinfektionen (HWI) beim Menschen. 
Von den sieben Virulenz-assozierten Genen war fyuA das am häufigsten vorkommende. Die 
Gesamtzahl an Virulenzfaktoren (VF) war am höchsten bei Isolaten, die zur Phylogruppe B2 
(mittlere Gesamtzahlrate 6, Hauptrate 5.5, Streubreite 3-7) gehören, am niedrigsten für Isolate 
der Phylogruppe C (0/ 0.5/ 0-3). Der häufigste ST in dieser Studie, ST410, wies die geringste 
Gesamtzahl an VF (0/ 0.3/ 0-2) auf. 
 
 
 
 
 
 
 
 
 
 
Schlüsselwörter:  
uropathogene Escherichia coli, Katze, Hund, MLST, Virulenzfaktoren 
 
  
  6 
Introduction 
 
Escherichia coli occurs naturally in the digestive tract of humans and animals as a 
commensal, however, some strains of E. coli can cause extraintestinal diseases, such as 
pneumonia, sepsis, meningitis and urinary tract infections (UTI) (Kaper et al., 2004).  
Commensal strains have been shown by phylogenetic analyses to be associated with 
phylogenetic group A, B1 or C, while virulent extraintestinal E. coli strains belong mainly to 
group B2 and, to a lesser extent, to group D, E, or F (Clermont et al., 2013). 
Uropathogenic E. coli (UPEC) is the most common etiologic agent of UTI in humans and 
animals (Foxman, 2010; Olin and Bartges, 2015). The ability of UPEC to cause disease is 
associated with the expression of specific virulence factors (VF) encoding adhesins, invasins, 
toxins and other proteins (Kaper et al., 2004).  
Among companion animals, E. coli clones that are found in the intestine may cause urinary 
tract infection (UTI) (Johnson et al., 2008b). Furthermore, UPEC may be acquired via 
external reservoirs: previous studies have demonstrated that humans and their companion 
animals can share pathogenic types of E. coli, including UPEC, indicating zoonotic as well as 
anthroponotic transmission (Johnson et al., 2008b; Johnson et al., 2008c; Johnson et al., 
2009). Other significant sources of pathogenic E. coli include raw meat canine diets and raw 
or inadequately cooked chicken meat (Glaser 2012; Schmidt et al., 2015).  
For uncomplicated UTI in cats and dog, the first-line therapeutic option is amoxicillin, with 
sulfamethoxazole/trimethoprim and fluoroquinolones remaining appropriate for complicated 
infections and pyelonephritis, respectively (Barsanti, 2012). The emergence of antimicrobial 
resistance among UPEC is of great concern and increases the risk of antimicrobial treatment 
failure in companion animals, as in humans.  
Understanding the prevalence of antimicrobial resistance and pathogenicity of UPEC isolated 
from cats and dogs is important both from veterinary medicine and public health perspectives, 
but information regarding the population structure and virulence association of UPEC from 
cats and dogs is still limited. 
The aim of this study was therefore to (i) assess the antimicrobial susceptibility of 
uropathogenic E. coli isolates obtained throughout 2012–2016 from Swiss dogs and cats, (ii) 
to detect and characterize plasmid-mediated resistance to third-generation cephalosporins, 
fluoroquinolones and azithromycin, (iii) to characterize the strains by phylogenetic grouping, 
multilocus sequence typing (MLST) and virulence profiling. 
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Materials and methods 
 
Bacterial isolates 
From a total of 205 Escherichia coli strains isolated between 2012 and 2016 from urine 
samples of companion animals admitted to the University of Zürich veterinary clinic, a total 
of 64 (35 ESBL-producing and 29 randomly selected non-ESBL producing) strains from 13 
cats and 51 dogs were analysed. Strain identification and preliminary antimicrobial 
susceptibility profiling was performed using VITEK 2 Compact system with AST GN38 
cards (Biomérieux, Marcy l’Etoile, France) according to the manufacturer’s instructions. 
 
Phenotypic and genotypic antimicrobial resistance testing 
Antimicrobial susceptibility testing was performed using the disk-diffusion method and the 
antibiotics ampicillin (AM), cefazolin (CZ), cefotaxime (CTX), amoxicillin with clavulanic 
acid (AMC), cefepime (FEP), nalidixic acid (NA), ciprofloxacin (CIP), 
sulfamethoxazole/trimethoprim (SXT), fosfomycin (FOS), nitrofurantoin (F/M), streptomycin 
(S), kanamycin (K), gentamicin (G), chloramphenicol (C) and tetracycline (TE) (Becton 
Dickinson, Allschwil, Switzerland). Results were interpreted according to Clinical and 
Laboratory Standards Institute (CLSI) performance standards (CLSI, 2016). Isolates 
displaying resistance to three or more classes of antimicrobials (counting beta-lactams as one 
class) were defined as multidrug-resistant (MDR). Synergistic effects between AMC and 
CTX and FEP were regarded as an indication of the presence of an ESBL producer (Kaur et 
al., 2013). 
For genotypic analyses, bacterial DNA was extracted using a standard heat lysis protocol. The 
presence of blaESBL genes belonging to the blaTEM, blaSHV, and blaCTX-M families was 
confirmed by PCR and amplicons were sequenced as described previously (Woodford et al., 
2006; Zurfluh et al., 2015). Ciprofloxacin resistant strains were examined for mutations in 
quinolone resistance-determining regions (QRDRs) of gyrA and parC, using previously 
described PCR and sequencing primers (Zurfluh et al., 2014). Screening all isolates for the 
plasmid-mediated fluoroquinolone resistance genes aac(6')-Ib-cr, qnrA, qnrB, qnrC, qnrD, 
qnrS, and qepA was carried out as described previously (Zurfluh et al., 2014). Further, all 
strains were screened for the plasmid-mediated azithromycin resistance gene mph(A) using 
previously described primers (Ojo et al., 2004). DNA samples from isolates described 
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previously were used as positive controls (Nüesch-Inderbinen et al., 2017; Zurfluh et al., 
2014). 
Synthesis of primers and DNA custom sequencing was carried out by Microsynth (Balgach, 
Switzerland) and nucleotide sequences were analysed with CLC Main Workbench 6.6.1. For 
database searches the BLASTN program of NCBI (http://www.ncbi.nlm.nih.gov/blast/) was 
used.  
 
Phylogenetic characterization and multilocus sequence typing 
The distribution of phylogenetic groups amongst the isolates was determined by the  
improved phylotyping PCR approach described by Clermont et al., targeting the genes chuA, 
yjaA, arpA and TspE4.C2 (Clermont et al., 2013). Isolates were thereby classified as 
belonging to one of the eight phylogenetic groups A, B1, B2, C, D, E, F, (E. coli sensu 
stricto), or Escherichia clade I. 
For multilocus sequence typing of E. coli isolates, internal fragments of the seven 
housekeeping genes (adk, fumC, gyrB, icd, mdh, purA, and recA) were amplified by PCR 
from DNA, as described by Wirth et al. (Wirth et al., 2006). Sequencing of the amplification 
products was performed by Microsynth (Balgach, Switzerland). Sequences were imported 
into the E. coli MLST database website (http://mlst.ucc.ie/mlst/dbs/Ecoli) to determine 
sequence types (STs). Alleles and STs that had not been previously described were designated 
new ST, but not assigned numerical designations, since whole-genome sequencing was not 
performed. 
 
Virulence factor (VF) determination 
All 64 strains were tested by conventional PCR for the presence of genes of VF that mediate 
adhesion (p-fimbrial adhesion genes papAH and papEF, and the chaperone-usher fimbria 
yfcv), toxins (-haemolysin hlyA), siderophores (the ferric yersiniabactin uptake protein 
fyuA), serum resistance (traT), and the right-hand terminus of pathogenicity island (PAI) from 
E. coli strain CFT073, using primers and conditions described previously (Johnson and Stell, 
2000; Spurbeck et al., 2012). The aggregate VF score was defined as the number of unique 
VF detected for each isolate, counting the PAI marker as one. 
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eBURST 
The Based Upon Related Sequence Types (eBURST) clustering algorithm in phyloviz 
(www.phyloviz.net) was used to visualise relationships between the isolates. 
 
 
Results 
 
Antimicrobial resistance 
Between 2012-2016, 205 E. coli strains were collected (41 in 2012, 121 in 2013, 17 in 2014, 
17 in 2015 and 9 in 2016). During these years, ESBL producers were detected in 10 (24.4%), 
12 (9.9%), 4(23.5%), 6 (35.3%), and 3 (33.3%) of the isolates, respectively. Resistance 
profiles of the 35 ESBL producing and 29 non-ESBL producing isolates to all 15 
antimicrobials tested are shown in detail in supplementary Table S1. Resistance rates to 
classes of antimicrobials commonly used for treating feline and canine E. coli UTIs are 
summarized in Table 1. 
Overall, 46 (71.9%) of the isolates were MDR (88.6% of the ESBL-producers, and 51.7% of 
the non-ESBL producers, respectively). The presence of blaESBL genes was confirmed and the 
genes were identified in 35 phenotypic ESBL producers as blaCTX-M-15 (n=17/48.6% of the 
blaESBLs), blaCTX-M-1 (n=10/28.6%), blaCTX-M-55 (n=4/11.4%), blaCTX-M-14 (n=3/8.6%), and 
blaCTX-M-27 (n=1/2.9%). Except for one blaCTX-M-1, all blaESBLs were detected in canine isolates. 
Overall, 51 (79.7%) of the isolates were resistant to nalidixic acid, and 47 thereof were 
ciprofloxacin resistant (Table 1 and supplementary Table S1). Among the isolates displaying 
ciprofloxacin resistance, all revealed chromosomal mutations that result in amino acid 
substitutions in GyrA and ParC (Table 2 and supplementary Table S1). The plasmid-mediated 
fluoroquinolone resistance genes aac(6')-Ib-cr and qnrB were detected in 17 (26.6% of all 
isolates), and one (1.6%) isolate, respectively, and were restricted to canine isolates (Table 3 
and supplementary Table S1). The plasmid-mediated azithromycin resistance gene mph(A) 
was found in 13 (20.3%) of the isolates. The majority (n= 15/88.2%) of the 17 isolates with 
plasmid-mediated fluoroquinolone resistance and the majority (n= 34/69.4%) of the 49 
isolates with chromosomally mediated quinolone resistance were ESBL producers (Table 3). 
Only 4 (6.3%) isolates were non-drug resistant (NDR) (supplementary Table S1). 
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Phylogenetic groups and ST  
As shown in Table 3, the most prevalent phylogenetic group was C (n=19 /29.7% of all 
isolates), followed by group B2 (n=15 /23.4%), B1 (n=10/15.6%), group A (n=9/14%), group 
F (n=8/12.5%), and group D (n=3/4.7%). None of the isolates belonged to phylogenetic group 
E or clade I. Among feline isolates, phylogenetic group B2 predominated (n=7 /53.8% of all 
feline isolates), whilst among canine isolates, the majority (n=18/35.3%) belonged to group C. 
MLST assigned the majority (n=39/60.9%) of the isolates to 9 different clonal complexes 
(CC): CC10 (n=3), CC12 (n=2), CC23 (n=17), CC73 (n=5) and CC131 (n=5), CC156 (n=1), 
CC354 (n=2), CC469 (n=1), and CC648 (n=3).  
Twenty-six different STs were identified, the three most common represented by ST410 
(n=16/25%), ST131, and ST73 (both n=5/7.8%). Less frequently occurring STs included 
ST533 (n=4/6.3%), and ST361, ST744 and ST648 (each n=3/4.7%, respectively). All other 
STs were represented by one or two isolates only (Table 3 and supplementary Table S1). 
Two new STs were detected, which however were not assigned numerical designations by the 
E. coli MLST database (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli). Figure 1 illustrates 
eBURST showing relationships between the isolates. The prevalence of the most common ST, 
ST410, was variable, declining from 50% in 2012 to 1% in 2015, with an increase to 33.3% 
observed for 2016. Of the 64 isolates, a total of 10 (15.6%) belonged STs frequently 
associated with human UTI (ST73 and ST131).  
The MDR, ESBL- and non-ESBL producers were distributed throughout phylogroups A, B1, 
B2, C, D and F. 
 
Distribution of VF genes 
Overall, 47 (73.4%) of the isolates tested positive for one or more of the VF genes (Table 3). 
Among the 64 isolates, the prevalence of individual VF genes was 53.1% for fyuA, 48.4% for 
traT, 34.4% for yfcv and PAI, 23.4% for hlyA, 20.3% for papAH, and 18.8% for papEF.  
The overall median aggregate VF score was highest for isolates belonging to phylogenetic 
group B2 (median aggregate VF score 6, mean score 5,5, range 3-7), followed by isolates 
from phylogenetic group F (3/ 2,9/1-4). Isolates assigned to phylogenetic group D scored 
2/2/2-2, and isolates of phylogenetic group A scored 1/1,8/ 0-6. The overall median aggregate 
VF scores were lowest for isolates belonging to phylogenetic group C (0/ 0.5/0-3).  
Among the most common STs in this study, ST131 harboured the highest number of VF 
(7/6,4/4-7), followed by ST73 (4/4,6/4-7), and ST648 (4/3,7/3-4). Of the most prevalent ST in 
this study, ST410 harboured the lowest number of VF (0/0,3/0-2). 
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VF scores were higher in NDR (4/3.8/3-4) than in MDR (1/1,9/0-7), higher in non-ESBL 
producing isolates (3/3/0-7) than in ESBL producers (1/1,7/0-7), and higher in isolates that 
did not harbour mph(A) (2/2,6/0-7), than those that harboured mph(A) (1/1,1/0-4). 
 
Discussion 
 
In this study, we assessed antimicrobial resistance, phylogenetic background, and virulence 
profiles of ESBL producing, and non-ESBL producing UPEC isolated from cats and dogs 
admitted to the veterinary clinic of the University of Zürich, Switzerland. In veterinary as in 
human medicine, antimicrobials are the cornerstone of treatment of bacterial UTI.  
Sulfamethoxazole/trimethoprim, amoxicillin/clavulanate, quinolones and chloramphenicol are 
antimicrobial compounds that are recommended for the treatment of feline and canine UTI 
due to infection with E. coli (Barsanti, 2012). Our data show that infection management may 
be compromised by the high rate of resistance to these drugs, similar to the situation /as 
described for UPEC in humans (Gibreel et al., 2012; Nicolle 2013; Nolan et al., 2015; 
Lavigne et al. 2016). Furthermore, of the 205 isolates from our strain collection, 35 (17%) 
were ESBL producers and the annual prevalence ranged from 9.9% to 35.3%. This is a 
remarkable increase compared to the prevalence of 7.5% ESBL producers among UPEC 
isolated from companion animals at our institution between 2010–2011 (Huber et al., 2013), 
and poses a threat to the efficacy of third-generation cephalosporins approved for use in 
veterinary medicine, such as cefovecin (Stegemann et al., 2006). Further, the high prevalences 
of 26.6% aac(6')-Ib-cr  and 13.6% mph(A) among the UPEC analysed in this study contrast 
noticeably with the 2.3% and 13.6%, respectively, observed for these genes in UPEC from 
human primary care patients in Switzerland (Nüesch-Inderbinen et al., 2017), and indicate 
that companion animals, particularly dogs, may serve as reservoirs for E. coli harbouring 
these resistance genes. 
In this study, we identified the phylogenetic groups based on the new Clermont method which 
enabled, besides the phylogenetic groups A, B1, B2, and D, the identification of groups C and 
F among the feline and canine UPEC. Our results show that in accordance to previous reports, 
UPEC isolates from cats frequently belonged to group B2 (Wagner et al., 2014; Liu et al., 
2015). However, overall, phylogroup C had the highest prevalence, a finding which is in 
contrast to previous studies of UPEC in animals as well as in humans that indicate the 
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predominance of extraintestinal, pathogenic group B2 (Barsanti, 2012; Gibreel et al., 2012). 
Data on the prevalences of phylogroups C, E, F and clade I among UPEC are rare, but a 
recent study shows that among human isolates, approximately 25% belong to these groups 
(Iranpour et al., 2015). Since 42.2% of the isolates belonged to the newly described 
phylogroups C and F, further studies are needed to provide a more refined understanding of 
the prevalences of phylogenetic groups among E. coli isolates of animal and human origin. 
Antimicrobial resistant as well as susceptible UPEC in humans are frequently associated with 
specific clonal complexes such as CC69, CC73, CC95, ST127, and CC131 (Lau et al., 2008; 
Gibreel et al., 2012). Some of these CCs or STs, such as CC73, ST127 and CC131 have also 
been described as etiological agents of UTI in companion animals (Johnson et al., 2008a; 
Johnson et al., 2009). Corresponding well with reports on human UPEC (Bengtsson et al., 
2012), we found 80% of the E. coli ST131 isolates to ESBL producers, and all of the ST73 
isolates to be non-ESBL producers. Overall, our data specified that 15.6% of UPEC from cats 
and dogs belong to STs commonly associated with UTI in humans and harbour urovirulence 
genes that are identical to those found in human isolates (Gibreel et al., 2012). Other STs 
found in this study, such as ST648 and ST410 are also associated with extraintestinal disease 
in humans and animals, but not specifically with UTI (Ewers et al., 2014; Falgenhauer et al. 
2016; Schaufler et al. 2016; Timofte et al., 2016). Therefore, although major UPEC clones 
described in human infection were not predominant, such strains exhibit reciprocal zoonotic 
potential, and should be considered a threat to pet owners and companion animals alike. 
The high prevalence of ST410 in ESBL-producing UPEC from dogs has been observed 
previously in Switzerland (Huber et al., 2013). This ST, assigned to phylogroup C, displayed 
inverse association of VF scores with MDR and with plasmid-mediated resistance to third-
generation beta-lactams, aminoglycosides and macrolides. This phenomenon was observed 
among other isolates belonging to phylogenetic groups A and C, suggesting that selective 
pressure, rather than virulence may be the driving force behind the high prevalence of ST410 
among canine UPEC. However, the panel of VFs selected for this study was limited in 
number and represents only a subset of known VFs. Other determinants of virulence may 
have been missed that may have shown a different tendency. Nevertheless, the high 
prevalence of isolates belonging to phylogenetic groups A, B1 and C indicate that the 
commensal flora of companion animals may play an important role in the aetiology of UTI. 
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The results of this study illustrate the need for further observation of E. coli causing disease in 
companion animals, as well as the prudent use of antimicrobials in veterinary medicine, 
including the use of third generation cephalosporins, fluoroquinolones and macrolides. 
 
Conclusions 
 
In conclusion, our findings showed that feline and canine UPEC population was characterized 
by a high prevalence of MDR. ESBLs producing UPEC were detected almost exclusively 
among canine isolates. Phylogenetic groups B2 and F were associated more frequently with 
VF than other groups. In this study, group C was the most predominant phylogenetic group 
and displayed the lowest number of VF. MLST revealed a diverse clonal structure, and 
detected STs that may pose an infectious threat to humans. The most frequent MLST was 
ST410, which was characterized by a high prevalence of plasmid-mediated resistance genes 
blaCTX-M-15, aac(6’)-Ib-cr and mph(A), and a low aggregate VF score.  
These results increase our current knowledge of the phenotypic and genotypic characteristics 
of feline and canine UPEC, and may be advantageous for future infection management and 
prevention. 
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Figure 1: MLST-based eBURST diagram depicting non-ESBL and ESBL producing UPEC 
isolated from cats and dogs. Each ST is represented by a circle, the size of which correlates to 
the frequency of the ST. Pie parts represent the number of strains within one ST. Exact 
numbers of isolates per ST are given in Table 3 and supplementary Table S1. Black outer 
rings show percentage of dog-derived strains from dogs, white outer rings show percentage of 
strains from cats. Isolates that tested negative by PCR for blaESBL genes are coloured grey. 
Isolates harbouring blaCTX-M-1 are depicted in blue, blaCTX-M-14 in red, blaCTX-M-15 in orange, 
blaCTX-M-27 in turquoise, blaCTX-M-55 in green. 
 
ST410
ST23 ST167
ST410
ST167
ST361
ST617
ST117
ST963
ST1177
No ST
ST457
ST744
ST88
ST372
ST23
ST1431
ST162
ST1642
ST156
ST224
ST73
ST1735
ST141
ST131
ST12
ST961
ST648
ST354
ST533
  19 
 
Table 1: Resistance rates of feline and canine UPEC to classes of antimicrobials used in the management of E. coli UTI  
in cats and dogs. 
 
 Antimicrobial class 
 ß-lactams  Folic acid 
synthesis  
inhibitors 
 Quinolones    
Host 
(n=64) 
Ampicillin/ 
clavulanic acid 
Cefotaxime  Sulfamethoxazol/ 
trimpethoprim 
 Naidixic 
acid 
Ciprofloxacin  Chloramphenicol Nitrofurantoin 
Cats 
(n=13) 
5 (38.5%) 5 (38.5%)  3 (23.1%)  7 (53.8%) 4 (30.8%)  4 (30.8%) 0 (0%) 
Dogs 
(n=51) 
22 (43.1%) 38 (74.5%)  30 (58.8%)  44 (86.3%) 43 (84.3%)  14 (27.5%) 2 (3.9%) 
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Table 2: Amino acid substitutions in the QRDR of 41 ciprofloxacin resistant UPEC isolates from cats and dogs. 
 
 
 QRDR 
 gyrA  parC 
Host (n=41) 
 
Ser83→Leu 
(%) 
Asp87→Asn 
(%) 
Asp87→Tyr 
(%) 
 Ser80→Ile 
(%) 
Glu84→Val 
(%) 
Glu84→Gly 
(%) 
Cats (n=4) 4 (100) 3 (75) 1 (25)  4 (100) 0 (0) 1 (25) 
Dogs (n=43) 43 (100) 39 (90.7) 3 (7)  43 (100) 4 (9.3) 4 (9.3) 
 
Asn, asparagine; Asp, aspartic acid; CIP, ciprofloxacin; Glu, glutamic acid; Gly, glycine; gyrA, DNA gyrase (type II topoisomerase) gene; Ile, 
isoleucine; Leu, leucine; parC, topoisomerase IV gene; QRDR, quinolone resistance determining region; Ser, serine; Tyr, tyrosine; Val, valine. 
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Table 3: Genotypic characteristics of feline and canine UPEC 
 
Host No. 
Isolates 
Phylogenetic 
group 
ST CC papAH papEF yfcv hlyA fyuA traT PAI Plasmid-mediated 
resistance gene(s) 
Cat 1 A 167 10 - - - - + + - mph(A) 
Dog 1 A 617 10 + + - + + + + blaCTX-M-1 
Dog 1 A 617 10 + + - - + + + blaCTX-M-1 
Dog 2 A 361 – - - - - - - - aac(6')-Ib-cr, blaCTX-M-15, mph(A) 
Dog 1 A 361 – - - - - + + - aac(6’)-Ib-cr, blaCTX-M-15, mph(A) 
Dog 1 A 744 – - - - - - + - blaCTX-M-14, mph(A) 
Dog 2 A 744 – - - - - - - - blaCTX-M-14 
Dog 1 B1 156 156 - - - - + - - - 
Dog 1 B1 162 469 - - - - + + - - 
Cat 1 B1 224 – - - - - - + - - 
Dog 1 B1 361 – - - - - - + - - 
Dog 1 B1 533 – - - - - - + - blaCTX-M-15, mph(A) 
Dog 2 B1 533 – - - - - - + - - 
Dog 1 B1 1431 – - - - + + + - blaCTX-M-1 
Dog 1 B1 1642 – - - - - - - - mph(A) 
Cat 1 B1 Nd nd - - - - - + - - 
Dog 1 B2 12 12 + + + + + - + - 
Cat 3 B2 73 73 - - + + + - + - 
Cat 1 B2 73 73 + + + + + + + - 
Dog 1 B2 73 73 - - + + + - + - 
Dog 2 B2 131 131 + + + + + + + aac(6’)-Ib-cr, blaCTX-M-15 
Dog 1 B2 131 131 + + + + + + + blaCTX-M 15 
Dog 1 B2 131 131 - - + - + + + blaCTX-M-27, mph(A) 
Dog 1 B2 131 131 + + + + + + + - 
Cat 1 B2 141 – + + + + + - + - 
Cat 1 B2 961 – + + + + + - + - 
Dog 1 B2 372 – - - + - + - + - 
Cat 1 B2 1735 – + + + + + - + - 
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Table 3-continued 
 
Host No. 
Isolates 
Phylogenetic 
group 
ST CC papAH papEF yfcv hlyA fyuA traT PAI Plasmid-mediated 
resistance gene(s) 
Dog 1 C 88 12 + - - - + + - - 
Cat 1 C 23 23 - - - - + - - blaCTX-M-1 
Dog 5 C 410 23 - - - - - - - aac(6’)-Ib-cr, blaCTX-M-15, 
Dog 5 C 410 23 - - - - - - - blaCTX-M-1 
Dog 2 C 410 23 - - - + - - - aac(6’)-Ib-cr, blaCTX-M-55, mph(A) 
Dog 1 C 410 23 + - - - + -  aac(6’)-Ib-cr, blaCTX-M-15, mph(A) 
Dog 1 C 410 23 - - - - - - - aac(6’)-Ib-cr, blaCTX-M-15, mph(A) 
Dog 1 C 410 23 - - - + - - - aac(6’)-Ib-cr 
Dog 1 C 410 23 - - - - - - - aac(6’)-Ib-cr 
Dog 1 C nd nd - - - + - - - aac(6’)-Ib-cr, blaCTX-M-15, mph(A), qnrB 
Dog 2 D 963 – - - - - + + - - 
Dog 1 D 1177 – - - - - + + - blaCTX-M-55 
Dog 1 F 354 354 - - + - - + - blaCTX-M-15 
Cat 1 F 354 354 - + + - - + - - 
Dog 1 F 457 – - - + - - + + blaCTX-M-55 
Dog 1 F 457 – - - + - - + + - 
Dog 1 F 648 648 - - + - + + + blaCTX-M-15 
Dog 1 F 648 648 - - + - - + + - 
Cat 1 F 648 648 - - + - + + + - 
Dog 1 F 117 – - -  - - + - blaCTX-M-1 
 
Abbreviations: aac(6’)-Ib-cr, aminoglycoside 6'-N-acetyltransferase variant; bla, ß-lactamase gene; CC, clonal complex; fyuA, ferric yersiniabactin uptake  
protein gene; hlyA, -haemolysin gene; mph(A), macrolide 2’-phosphotransferase gene; PAI, right-hand terminus of pathogenicity island; papAH  
and papEF, p-fimbrial adhesion genes; qnrB, quinolone resistance gene; ST, sequence type; traT, serum resistance gene; yfcv, chaperone-usher  
fimbria gene; +, presence of a trait; -, absence of a trait; –, not applicable. 
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